Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Wagner, D; Amrein, K; Dimai, HP; Kniepeiss, D; Tscheliessnigg, KH; Kornprat, P; Dobnig, H; Pieber, T; Fahrleitner-Pammer, A.
Ibandronate and calcitriol reduces fracture risk, reverses bone loss, and normalizes bone turnover after LTX.
Transplantation. 2012; 93(3):331-336 Doi: 10.1097/TP.0b013e31823f7f68 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz

Wagner Doris

Co-Autor*innen der Med Uni Graz

Amrein Karin

Dimai Hans Peter

Dobnig Harald

Fahrleitner-Pammer Astrid

Kniepeiss Daniela

Kornprat Peter

Pieber Thomas

Tscheliessnigg Karlheinz

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Osteoporosis is a common complication in long-term survivors after liver transplantation (LTX). This study investigates the influence of a combination therapy of low dose parenteral ibandronate (IBN) and calcitriol on top of calcium and vitamin D supplementation in such patients. For 3 years, 30 osteoporotic patients after LTX (28±6 months) were treated with quarterly 2 mg IBN intravenously and daily calcitriol (0.25-1.0 μg) on top of 1000 mg calcium and 800 IU vitamin D. Recipients with normal bone density (n=24) were enrolled as controls. Laboratory analysis and dual energy X-ray absorptiometry were performed at baseline and every 12 months. Primary endpoints were changes in bone mineral density and fracture incidence. IBN patients showed a significant increase of bone mineral density at the femoral neck and the trochanteric region (13% and 15%, respectively, both P=0.001) as compared with baseline whereas the control group revealed a small but significant loss of -5.0% in the trochanteric and -4.9% in the neck region (P<0.05) over the same time period. Fracture incidence was low among IBN patients (7%); however, 23% of the control patients sustained at least one vertebral fracture. The relative fracture risk was 3.21 for IBN patients (95% confidence interval, 0.6-20.9, P=0.03) resulting in an absolute risk reduction for a new vertebral fracture of 14%. In LTX recipients with osteoporosis combination therapy with low dose IBN and calcitriol on top of calcium and vitamin D supplementation is an effective treatment option.

Find related publications in this database (using NLM MeSH Indexing)

Alkaline Phosphatase - blood

Bone Density -

Bone Density Conservation Agents - administration & dosage

Bone Remodeling - drug effects

Calcitriol - administration & dosage

Diphosphonates - administration & dosage

Drug Therapy, Combination -

Female -

Fractures, Bone - prevention & control

Humans -

Liver Transplantation - adverse effects

Male -

Middle Aged -

Osteoporosis - drug therapy

Parathyroid Hormone - blood

Risk -

Find related publications in this database (Keywords)

Liver transplantation

Immunosuppression

Osteoporosis

Ibandronate

Calcitriol

Secondary hyperparathyroidism

Renal insufficiency

© Med Uni Graz • Impressum